The capacity of H3R inverse agonists/antagonists to reduce food intake has also been shown to minimize weight gain occurring in models of diet-induced obesity and to reduce body weight in obese rodents (108–112). This evidence concerns the gene HRH3 and obesity due to melanocortin 4 receptor deficiency.